Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease

Amikacin liposome inhalation suspension (ALIS; Arikayce(®)) [formerly known as liposomal amikacin for inhalation, or LAI] is a liposomal formulation of the aminoglycoside antibacterial drug amikacin. The ALIS formulation, administered via inhalation following nebulization, is designed to facilitate...

Descripción completa

Detalles Bibliográficos
Autor principal: Shirley, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Adis Drug Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445814/
https://www.ncbi.nlm.nih.gov/pubmed/30877642
http://dx.doi.org/10.1007/s40265-019-01095-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445814/
https://www.ncbi.nlm.nih.gov/pubmed/30877642
http://dx.doi.org/10.1007/s40265-019-01095-z

Ejemplares similares